The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Afamelanotide for Erythropoietic Protoporphyria
Open accessAbstract
BACKGROUND: Erythropoietic protoporphyria is a severe photodermatosis that is associated with acute phototoxicity. Patients with this condition have excruciating pain and a markedly reduced quality of life. We evaluated the safety and efficacy of an α-melanocyte-stimulating hormone analogue, afamelanotide, to decrease pain and improve quality of life. METHODS: We conducted two multicenter, randomized, double-blind, placebo-controlled trials of subcutaneous implants containing 16 mg of afamelanotide. Patients in the European Union (74 patients) and the United States (94 patients) were randomly assigned, in a 1:1 ratio, to receive a subcutaneous implant containing either afamelanotide or placebo every 60 days (a total of five implants in the European Union study and three in the U.S study). The type and duration of sun exposure, number and severity of phototoxic reactions, and adverse events were recorded over the respective 180-day and 270-day study periods. Quality of life was assessed with the use of validated questionnaires. A subgroup of U.S. patients underwent photoprovocation testing. The primary efficacy end point was the number of hours of direct exposure to sunlight without pain. RESULTS: In the U.S. study, the duration of pain-free time after 6 months was longer in the afamelanotide group (median, 69.4 hours, vs. 40.8 hours in the placebo group; P=0.04). In the European Union study, the duration of pain-free time after 9 months was also longer in the afamelanotide group than in the placebo group (median, 6.0 hours vs. 0.8 hours; P=0.005), and the number of phototoxic reactions was lower in the the afamelanotide group (77 vs. 146, P=0.04). In both trials, quality of life improved with afamelanotide therapy. Adverse events were mostly mild; serious adverse events were not thought to be related to the study drug. CONCLUSIONS: Afamelanotide had an acceptable side-effect and adverse-event profile and was associated with an increased duration of sun exposure without pain and improved quality of life in patients with erythropoietic protoporphyria. (Funded by Clinuvel Pharmaceuticals and others; ClinicalTrials.gov numbers, NCT01605136 and NCT00979745.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sawyer, T. K., Sanfilippo, P. J., Hruby, V. J., Engel, M. H., Heward, C. B., Burnett, J. B., & Hadley, M. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.5754 · Cited by 575
Kollias, N., Sayre, R. M., Zeise, L., & Chedekel, M. R. (1991) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(91)80147-a · Cited by 482
Photoprotection by melanin—a comparison of black and Caucasian skin
Kaidbey, K. H., Agin, P. P., Sayre, R. M., & Kligman, A. M. (1979) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(79)70018-1 · Cited by 467
The function of melanin or six blind people examine an elephant
Hill, H. Z. (1992) · BioEssays · doi:10.1002/bies.950140111 · Cited by 332
Brzoska, T., Luger, T. A., Maaser, C., Abels, C., & Böhm, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0027 · Cited by 323
Whatley, S. D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M. N., Elder, G. H., Holme, S. A., Anstey, A. V., Parker, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.003 · Cited by 293
Self-citationDisorders of heme biosynthesis : X-linked sideroblastic anemia and the porphyrias
Anderson, K. (2001) · Medical Entomology and Zoology · Cited by 247
Self-citationLecha, M., Puy, H., & Deybach, J.-C. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-19 · Cited by 225
Self-citationRole of melanin as a scavenger of active oxygen species
BUSTAMANTE, J., BREDESTON, L., MALANGA, G., & MORDOH, J. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00612.x · Cited by 222
Molecular characterization of melanocyte stem cells in their niche
Osawa, M., Egawa, G., Mak, S.-S., Moriyama, M., Freter, R., Yonetani, S., Beermann, F., & Nishikawa, S.-I. (2005) · Development · doi:10.1242/dev.02161 · Cited by 209
How to make a melanoma: what do we know of the primary clonal events?
Bennett, D. C. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2007.00433.x · Cited by 198
Porphyrin and Heme Metabolism and the Porphyrias
Bonkovsky, H. L., Guo, J., Hou, W., Li, T., Narang, T., & Thapar, M. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120006 · Cited by 190
Self-citationGouya, L., Martin-Schmitt, C., Robreau, A.-M., Austerlitz, F., Da Silva, V., Brun, P., Simonin, S., Lyoumi, S., Grandchamp, B., Beaumont, C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/498620 · Cited by 187
Self-citationTODD, D. J. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08577.x · Cited by 171
Liver transplantation for erythropoietic protoporphyria liver disease
McGuire, B. M., Bonkovsky, H. L., Carithers, R. L., Chung, R. T., Goldstein, L. I., Lake, J. R., Lok, A. S., Potter, C. J., Rand, E., Voigt, M. D., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20620 · Cited by 163
Self-citationPorphyrins, porphyrin metabolism and porphyrias. I. Update
Thunell, S. (2000) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655100448310 · Cited by 133
Hauser, J. E., Kadekaro, A. L., Kavanagh, R. J., Wakamatsu, K., Terzieva, S., Schwemberger, S., Babcock, G., Rao, M. B., Ito, S., & Abdel‐Malek, Z. A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00315.x · Cited by 128
An α-Melanocyte–Stimulating Hormone Analogue in Erythropoietic Protoporphyria
Harms, J., Lautenschlager, S., Minder, C. E., & Minder, E. I. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0805682 · Cited by 123
Bloomer, J. R. (1988) · Hepatology · doi:10.1002/hep.1840080235 · Cited by 118
Self-citationLong-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria
Biolcati, G., Marchesini, E., Sorge, F., Barbieri, L., Schneider‐Yin, X., & Minder, E. I. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13598 · Cited by 108
Balwani, M., Doheny, D. O., Bishop, D. F., Nazarenko, I. A., Yasuda, M., Dailey, H. A., Anderson, K. E., Bissell, D. M., Bloomer, J. R., Bonkovsky, H. L., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00340 · Cited by 101
Self-citationMinder, E. I., Schneider-Yin, X., Steurer, J., & Bachmann, L. M. (2009) · PubMed · doi:10.5167/uzh-31429 · Cited by 97
Wåhlin, S., Flodérus, Y., Stal, P. I., & Harper, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02236.x · Cited by 89
The Role of α‐MSH as a Modulator of Cutaneous Inflammation
Luger, T. A., Brzoska, T., Scholzen, T. E., Kalden, D.-H., Sunderkötter, C. H., ARMSTRONG, C., & Ansel, J. C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05388.x · Cited by 87
Haylett, A. K., Nie, Z., Brownrigg, M., Taylor, R., & Rhodes, L. E. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10104.x · Cited by 73
Self-citationA review and update on melanocyte stimulating hormone therapy: afamelanotide.
Fabrikant, J., Touloei, K., & Brown, S. M. (2013) · PubMed · Cited by 49
Harms, J., Lautenschlager, S., Minder, C. E., & Minder, E. I. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00595.x · Cited by 49
Thunell, P. H. S. (2000) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655100448338 · Cited by 48
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria
Minder, E. I., & Schneider‐Yin, X. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.956089 · Cited by 26
Erythropoietic Protoporphyria, Autosomal Recessive
Balwani, M., Bloomer, J. R., & Desnick, R. J. (2014) · Europe PMC (PubMed Central) · Cited by 25
Self-citationMandarino, L. J. (1984) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(84)90589-9 · Cited by 21
Evidence and conjecture about mechanisms of cutaneous disease in photodermatology
Porter, R. M., & Anstey, A. V. (2014) · Experimental Dermatology · doi:10.1111/exd.12467 · Cited by 19
Self-citationTollånes, M. C., Aarsand, A. K., Villanger, J. H., Støle, E., Deybach, J., Marsden, J. T., To‐Figueras, J., Sandberg, S., & On behalf of the European Porphyria Network (EPNET) (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-93 · Cited by 18
Self-citation
Cited by
Bissell, D. M., Anderson, K. E., & Bonkovsky, H. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1608634 · Cited by 399
Self-citationProtoporphyrin IX: the Good, the Bad, and the Ugly
Sachar, M., Anderson, K. E., & Ma, X. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228130 · Cited by 257
Self-citationPasseron, T., Lim, H. W., Goh, C. ‐., Kang, H. Y., Ly, F., Morita, A., Ocampo Candiani, J., Puig, S., Schalka, S., Wei, L., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17242 · Cited by 221
Self-citationClinical guide and update on porphyrias
Stölzel, U., Doss, M. O., & Schuppan, D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.050 · Cited by 175
Visible light. Part II: Photoprotection against visible and ultraviolet light
Geisler, A. N., Austin, E., Nguyen, J., Hamzavi, I., Jagdeo, J., & Lim, H. W. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.11.074 · Cited by 118
Self-citation
Metadata
- Authors
- Langendonk, J. G., Balwani, M., Anderson, K. E., Bonkovsky, H. L., Anstey, A. V., Bissell, D. M., Bloomer, J., Edwards, C., Neumann, N. J., Parker, C., Phillips, J. D., Lim, H. W., Hamzavi, I., Deybach, J.-C., Kauppinen, R., Rhodes, L. E., Frank, J., Murphy, G. M., Karstens, F. P. J., Sijbrands, E. J. G., de Rooij, F. W. M., Lebwohl, M., Naik, H., Goding, C. R., Wilson, J. H. P., & Desnick, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-07-02
- Volume
- 373
- Issue
- 1
- Pages
- 48-59
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2180660046
- Cited by
- 283
- References
- 33
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.